| abstract |
The present invention relates to carbonylamino derivatives of general formula I (see formula) wherein R means lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, lower alkoxy or CF3; R1 means hydrogen or lower alkyl, R2 and R3 mean, independently of each other, hydrogen, halogen or nitro; Y means CH or N; n is 0-6; m is 0-2; as well as its pharmaceutically acceptable salts, for the treatment of diseases, related to antagonists and / or agonists of the metabotropic glutamate receptor. |